Latest News in the pharma Industry
Market News
ReadCoor to commercially launch spatial sequencing platform
10 Jan 2020
Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine.
Read more
Mylan recalls batches of Nizatidine capsules after nitrosamine detected in API
9 Jan 2020
The US arm of generic and specialty pharma company Mylan Pharmaceuticals has recalled three lots of its heartburn drug Nizatidine in capsule form amid fears of possible nitrosamine contamination.
Read more
New HQ for developer of world's first fully automated drug discovery platform
8 Jan 2020
End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data.
Read more.jpg)
Catalent completes purchase of biologics fill-finish and oral solid dose facility
7 Jan 2020
Facility provides European customers with great biologics and oral dose capabilities that can help reduce time-to-market.
Read more
WuXi STA opens large-scale oligonucleotide manufacturing facility
6 Jan 2020
Expands company's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial.
Read more
Boxing clever: Smart packs improving communication with patients
6 Jan 2020
Drug industry expectations of packaging are evolving with developers now seeking techs that help patients get more from their medicines.
Read more
NIH researchers discover new autoinflammatory disease
3 Jan 2020
Mutations in the RIPK1 gene responsible for CRIA syndrome.
Read more
UCB to build new biotech manufacturing plant in Belgium
31 Dec 2019
Capacity to serve global late-stage development and commercial manufacturing of monoclonal antibody drug substance to support new product launches.
Read more
BioAscent scientists help identify potential new treatments for cancer
30 Dec 2019
Collaboration discovers potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.
Read more.jpg)
Astellas strengthens immuno-oncology pipeline with acquisition of Xyphos Biosciences
27 Dec 2019
Acquisition adds talent and proprietary therapeutic platform to accelerate next-generation cancer immunotherapy.
Read more.jpg)
Botox still looking good on 30th anniversary
24 Dec 2019
Botox and Botox Cosmetic (onabotulinumtoxinA) hold 14 therapeutic and aesthetic indications combined, more than any other neurotoxin in the world.
Read more.jpg)
Colorcon launches on-dose authentication technology platform
23 Dec 2019
Next-generation pharmaceutical supply-chain security for tracking product from plant to patient.
Read more